Literature DB >> 14640558

Guanidino N-substituted and N,N-disubstituted derivatives of the kappa-opioid antagonist GNTI.

Shannon L Black1, Cedric Chauvignac, Peter Grundt, Carl N Miller, Susan Wood, John R Traynor, John W Lewis, Stephen M Husbands.   

Abstract

Derivatives of the highly selective kappa-opioid receptor antagonist GNTI (2a) have been prepared. Binding and functional studies conducted on cloned human opioid receptors expressed in Chinese hamster ovarian (CHO) cells suggested that adding a benzyl or a substituted benzyl group to the guanidino moiety led, in general, to a retention of high kappa-affinity and antagonist potency. Disubstitution of the guanidino moiety led to reduced kappa-selectivity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14640558     DOI: 10.1021/jm0309203

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  7 in total

1.  Exploring the structure of opioid receptors with homology modeling based on single and multiple templates and subsequent docking: a comparative study.

Authors:  Indrani Bera; Aparna Laskar; Nanda Ghoshal
Journal:  J Mol Model       Date:  2010-07-27       Impact factor: 1.810

Review 2.  Kappa opioid antagonists: past successes and future prospects.

Authors:  Matthew D Metcalf; Andrew Coop
Journal:  AAPS J       Date:  2005-10-27       Impact factor: 4.009

3.  Solid-phase synthesis of a library of amphipatic hydantoins. Discovery of new hits for TRPV1 blockade.

Authors:  Guillermo Gerona-Navarro; Rosario González-Muñiz; Asia Fernández-Carvajal; José M González-Ros; Antonio Ferrer-Montiel; Cristina Carreño; Fernando Albericio; Miriam Royo
Journal:  ACS Comb Sci       Date:  2011-07-08       Impact factor: 3.784

4.  Norbornane-based cationic antimicrobial peptidomimetics targeting the bacterial membrane.

Authors:  Shane M Hickey; Trent D Ashton; Gareth Boer; Christie A Bader; Michael Thomas; Alysha G Elliott; Carsten Schmuck; Heidi Y Yu; Jian Li; Roger L Nation; Matthew A Cooper; Sally E Plush; Douglas A Brooks; Frederick M Pfeffer
Journal:  Eur J Med Chem       Date:  2018-10-03       Impact factor: 6.514

5.  In Vitro, In Vivo and In Silico Characterization of a Novel Kappa-Opioid Receptor Antagonist.

Authors:  Kristina Puls; Aina-Leonor Olivé-Marti; Szymon Pach; Birgit Pinter; Filippo Erli; Gerhard Wolber; Mariana Spetea
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-28

6.  Inhibitory effect of lidocaine on pain and itch using formalin-induced nociception and 5'-guanidinonaltrindole-induced scratching models in mice: behavioral and neuroanatomical evidence.

Authors:  Saadet Inan; Nae J Dun; Alan Cowan
Journal:  Eur J Pharmacol       Date:  2009-06-21       Impact factor: 4.432

7.  Nalfurafine prevents 5'-guanidinonaltrindole- and compound 48/80-induced spinal c-fos expression and attenuates 5'-guanidinonaltrindole-elicited scratching behavior in mice.

Authors:  S Inan; N J Dun; A Cowan
Journal:  Neuroscience       Date:  2009-06-10       Impact factor: 3.590

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.